Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon

scientific article published on 15 October 2015

Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1040001G
P356DOI10.1371/JOURNAL.PONE.0140001
P932PMC publication ID4607444
P698PubMed publication ID26469186
P5875ResearchGate publication ID282875391

P50authorJulius AtashiliQ115147099
P2093author name stringBrian W Pence
Kathryn Whetten
Bradley N Gaynes
Rachel Whetten
Peter Ndumbe
Alfred K Njamnshi
Julie K O'Donnell
Charles Kefie Arrey
Mbu Eyongetah Tabenyang
P2860cites workThe reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample.Q51919185
Integrating mental health in global initiatives for HIV/AIDS.Q51928404
Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side EffectsQ57616039
Visual Analog Scale of ART AdherenceQ59392832
???Q26853444
The PHQ-9: validity of a brief depression severity measureQ24550620
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV cliniciansQ26823842
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--IIQ28260514
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot studyQ33276945
What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic reviewQ33570869
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, CameroonQ33610827
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in CameroonQ34364182
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVQ35526694
Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patientsQ36069977
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in CameroonQ36406374
Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian settingQ36501138
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.Q36572744
Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug useQ36691851
Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatmentQ36804300
Delivering happiness: translating positive psychology intervention research for treating major and minor depressive disordersQ37896634
Treatment of depression in individuals living with HIV/AIDS.Q38079100
HIV/AIDS and mental health research in sub-Saharan Africa: a systematic reviewQ38414099
Effectiveness of collaborative care for depression in human immunodeficiency virus clinics.Q38495944
Depression in the pathway of HIV antiretroviral effects on sexual risk behavior among patients in UgandaQ38869222
You want to measure coping but your protocol's too long: consider the brief COPE.Q39131700
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACQ41752733
Depression severity and drug injection HIV risk behaviorsQ42607096
Psychiatric disorders among the HIV-positive population in Nigeria: a control studyQ43466666
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United StatesQ43694055
Prevalence and correlates of HIV risk behaviors among drug users in ChinaQ44915426
Prevalence of HIV/AIDS and psychiatric disorders and their related risk factors among adults in Epworth, ZimbabweQ46631118
Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patientsQ46842472
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectCameroonQ1009
P304page(s)e0140001
P577publication date2015-10-15
P1433published inPLOS OneQ564954
P1476titleChanges in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon
P478volume10

Reverse relations

cites work (P2860)
Q36265139Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects
Q37234729Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel
Q40298887Attitudes of Indian HIV Clinicians Toward Depression in People Living with HIV.
Q43923810Changes in Anxiety and Depression Symptoms Predict Sexual Risk Behaviors Among Young Men Living in Dar es Salaam, Tanzania.
Q51736507Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.
Q30381514Community mental health care worldwide: current status and further developments
Q40074164Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression
Q99629917Correlates of Anxiety and Depression among Young Men Living in Dar es Salaam, Tanzania
Q36288348Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender
Q64238102Digital depression screening in HIV primary care in South Africa: mood in retroviral + application monitoring [MIR + IAM]
Q99609278Effectiveness of a peer-led adolescent mental health intervention on HIV virological suppression and mental health in Zimbabwe: protocol of a cluster-randomised trial
Q62489186Integrating depression management into HIV primary care in central Malawi: the implementation of a pilot capacity building program
Q59802844Mental health and HIV: research priorities related to the implementation and scale up of 'treat all' in sub-Saharan Africa
Q58551864Prevalence and correlates of depression among caregivers of children living with HIV in Ghana: findings from the Sankofa pediatric disclosure study
Q53697121Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium.
Q40049932Systematic Review of Interventions for Depression for People Living with HIV in Africa
Q91978251The Role of Depression Screening and Treatment in Achieving the UNAIDS 90-90-90 Goals in Sub-Saharan Africa
Q93050318The effectiveness of depression management for improving HIV care outcomes in Malawi: protocol for a quasi-experimental study
Q94570362The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi

Search more.